GSK drug Jemperli met the main goal of a pivotal Phase 2 test in patients with a rare type of rectal cancer, paving the way for regulatory submissions. This antibody drug has already received a voucher to speed up its review under a new FDA pilot program. The post GSK Eyes FDA Filing After Immunotherapy…
Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for underrepresented patients. The post Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials appeared first on MedCity News.
A couple of months back I hosted a conversation about my favorite topics, primary care and how telehealth and AI are changing it. The panel was Timm Schneider — Co-Founder & COO, Third Way Health, Jamie Reddick — COO, Graybill Medical Group & Erin Parks, Ph.D. — Co-Founder, Equip. The panel was at a tech…
Healthcare cybersecurity is no longer just about protecting electronic health records. It is increasingly about protecting the research, algorithms, clinical data, and intellectual property that drive the next generation of medicine. The post Healthcare Must Protect Innovation, Not Just Patient Data appeared first on MedCity News.
Focusing on two gene variants obscures the more complex gene relationships that drive obesity. Here’s what we miss if we only focus on one gene variant at a time. The post Obesity Is Tied to Hundreds of Gene Variants — Why Are We Only Talking About Two? appeared first on MedCity News.
If we want more nurses, we need more nursing students, which means creating the educational infrastructure needed to help them succeed. The post To Solve the Nursing Shortage, Our Leaders in Washington Must Invest in Higher Education appeared first on MedCity News.
SACRAMENTO, Calif. — Sen. John Kennedy of Louisiana is taking aim at California’s Medicaid program for providing housing assistance, food, and other social services to high-need, low-income patients who tend to rack up big healthcare costs and, he argued, strain taxpayer funds. The Republican blasted California during back-to-back political attacks in May, saying the heavily…
A former Mayo Clinic research director claims she was silenced, demoted and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation. The post Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know appeared…
CMS’s new GLP-1 Bridge program expands Medicare access to obesity drugs but raises concerns about cost, supply and implementation challenges. The post Does CMS Know What It Is Doing With Its GLP-1 Obesity Coverage Pilot? appeared first on MedCity News.
AstraZeneca is getting rights to a Sino Biopharmaceutical drug that offers a dual mechanism to treat chronic obstructive pulmonary disease, or COPD. It’s the same approach as an FDA-approved drug that Merck acquired last year in a multi-billion dollar deal. The post AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug…